feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouIndiaIndia
You
bookmarksYour BookmarkshashtagYour Topics
Trending
Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2026 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / Nasal Spray Overuse: Pharmacists Warn of Rebound Congestion

Nasal Spray Overuse: Pharmacists Warn of Rebound Congestion

10 Jan

•

Summary

  • Extended nasal spray use causes rebound congestion, worsening symptoms.
  • Almost six in 10 pharmacists report public unawareness of overuse dangers.
  • Royal Pharmaceutical Society urges clearer packaging and pharmacist advice.
Nasal Spray Overuse: Pharmacists Warn of Rebound Congestion

Individuals using nasal decongestant sprays are urged to limit their use to a maximum of seven days. Prolonged use risks a condition known as 'rebound congestion,' or rhinitis medicamentosa, where symptoms paradoxically worsen and patients become reliant on the sprays to breathe. This is a significant concern, as a survey by the Royal Pharmaceutical Society found that 59% of pharmacists believe the public is not aware of these dangers.

The survey also indicated that 74% of pharmacists feel the packaging for these sprays should be more explicit about the seven-day usage limit. Consequently, almost two-thirds (63%) of pharmacists have intervened in cases where they suspected overuse. Professor Amira Guirguis of the RPS emphasized the need for clearer warnings and greater public understanding of the risks associated with exceeding the recommended duration.

trending

Vedanta demerger gets final nod

trending

Chennai weather: heavy rain alert

trending

POCO M8 5G launch

trending

Rishabh Pant ruled out

trending

Kohli nears Tendulkar's record

trending

Nigeria beats Algeria in AFCON

trending

India vs New Zealand ODI

trending

Chelsea beats Charlton 5-1

trending

Sixers vs Hurricanes BBL match

Recent NHS data also highlights a surge in hospitalizations due to winter viruses, with flu cases seeing a slight increase in the week ending January 4, 2026. Alongside this, there has been a sharp rise in patients experiencing prolonged waits in ambulances outside hospitals, with 33% waiting at least 30 minutes for handover to A&E teams in the past week.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
Rebound congestion, or rhinitis medicamentosa, is a condition where overuse of nasal decongestant sprays causes symptoms to worsen and leads to dependency.
The Royal Pharmaceutical Society advises limiting nasal decongestant spray use to a maximum of seven days to avoid rebound congestion.
If your congestion persists after seven days of using nasal sprays, you should speak to your pharmacist for safe and effective alternative options.

Read more news on

Healthside-arrow

You may also like

Doctors Warn: 'Worst is Far From Over' for NHS

9 Jan • 12 reads

article image

AbbVie Eyes Revolution Medicines in Cancer Deal

8 Jan • 24 reads

article image

WHO Obesity Guidelines: New Era for Weight-Loss Drugs

5 Dec, 2025 • 193 reads

article image

Holiday Hazards: Food, Jabs, and Fairy Lights!

2 Dec, 2025 • 183 reads

article image

NHS Alert: Critical Gabapentin Reactions Requiring Emergency Help

29 Nov, 2025 • 213 reads

article image